Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Income from Continuing Operations (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Income from Continuing Operations data on record, last reported at 16782000.0 in Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 11.4% year-over-year to 16782000.0; the TTM value through Sep 2025 reached 65250000.0, down 4.52%, while the annual FY2024 figure was 60091000.0, 33.13% up from the prior year.
  • Income from Continuing Operations reached 16782000.0 in Q3 2025 per SNTI's latest filing, down from 16528000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 1178.0 in Q1 2021 and bottomed at 43293000.0 in Q3 2023.
  • Average Income from Continuing Operations over 5 years is 14409209.05, with a median of 15937000.0 recorded in 2024.
  • Peak YoY movement for Income from Continuing Operations: plummeted 997692.87% in 2022, then surged 65.2% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 3857088.0 in 2021, then crashed by 306.16% to 15666000.0 in 2022, then decreased by 16.63% to 18272000.0 in 2023, then grew by 12.78% to 15937000.0 in 2024, then fell by 5.3% to 16782000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 16782000.0 in Q3 2025, 16528000.0 in Q2 2025, and 16003000.0 in Q1 2025.